Navigation section

mg/0.3

  1. Cipla gets final USFDA approval for Lanreotide injection to treat tumors

    Cipla gets final USFDA approval for Lanreotide injection to treat tumors

    Acromegaly is a hormonal disorder, while GEP-NET is a rare type of tumor that can form in the pancreas or other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix.The company said it has received final approval for lanreotide injection in...
    • NewsBot
    • Article
    • 1 min read
    • acromegaly approval depot form gep-net hormonal injection lanreotide mg/0.3 mg/0.5 pancreas rare somatulin tumor type
    • Category: Technology & Innovation
Back
Top